MA20316A1 - Compose antibiotique,procede pour le preparer et compositions les contenant - Google Patents

Compose antibiotique,procede pour le preparer et compositions les contenant

Info

Publication number
MA20316A1
MA20316A1 MA20540A MA20540A MA20316A1 MA 20316 A1 MA20316 A1 MA 20316A1 MA 20540 A MA20540 A MA 20540A MA 20540 A MA20540 A MA 20540A MA 20316 A1 MA20316 A1 MA 20316A1
Authority
MA
Morocco
Prior art keywords
same
preparing
compositions containing
antibiotic compound
antibiotic
Prior art date
Application number
MA20540A
Other languages
English (en)
Inventor
Veikko Marttila Esko
Antero Uotila Jakko
Lauri Antero Marvola Marti
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of MA20316A1 publication Critical patent/MA20316A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring (AREA)
MA20540A 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant MA20316A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK5884A DK149776C (da) 1984-01-06 1984-01-06 Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen

Publications (1)

Publication Number Publication Date
MA20316A1 true MA20316A1 (fr) 1985-10-01

Family

ID=8089251

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20540A MA20316A1 (fr) 1984-01-06 1985-01-02 Compose antibiotique,procede pour le preparer et compositions les contenant

Country Status (38)

Country Link
US (1) US4599326A (fr)
JP (1) JPS60158197A (fr)
KR (1) KR900006237B1 (fr)
AT (1) AT386414B (fr)
AU (1) AU565688B2 (fr)
BE (1) BE901411A (fr)
BG (1) BG43189A3 (fr)
CA (1) CA1224461A (fr)
CH (1) CH666275A5 (fr)
CS (1) CS247191B2 (fr)
CY (1) CY1462A (fr)
DE (1) DE3500179A1 (fr)
DK (1) DK149776C (fr)
ES (1) ES8605818A1 (fr)
FI (1) FI77249C (fr)
FR (1) FR2557878B1 (fr)
GB (1) GB2152502B (fr)
HK (1) HK11590A (fr)
HU (1) HU196221B (fr)
IE (1) IE57967B1 (fr)
IL (1) IL73885A (fr)
IS (1) IS2968A7 (fr)
IT (1) IT1184304B (fr)
KE (1) KE3841A (fr)
LU (1) LU85721A1 (fr)
MA (1) MA20316A1 (fr)
MX (1) MX156277A (fr)
NL (1) NL8403979A (fr)
NO (1) NO160263C (fr)
NZ (1) NZ210606A (fr)
PH (1) PH22471A (fr)
PL (1) PL144349B1 (fr)
PT (1) PT79777B (fr)
RO (1) RO91262B (fr)
SE (1) SE461854B (fr)
SU (1) SU1410866A3 (fr)
YU (1) YU44485B (fr)
ZA (1) ZA8410143B (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
JP3382159B2 (ja) * 1998-08-05 2003-03-04 株式会社東芝 情報記録媒体とその再生方法及び記録方法
CA2491572C (fr) * 2002-07-05 2010-03-23 Collegium Pharmaceutical, Inc. Compositions pharmaceutiques empechant la consommation abusive d'opioides et d'autres drogues
US10004729B2 (en) 2002-07-05 2018-06-26 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
US8840928B2 (en) 2002-07-05 2014-09-23 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
JP2007509973A (ja) * 2003-10-31 2007-04-19 アルザ・コーポレーシヨン 増強された吸収のための組成物および投与形態物
DK1765292T3 (en) 2004-06-12 2018-01-02 Collegium Pharmaceutical Inc ABUSE PREVENTIONAL PHARMACEUTICAL FORMULATIONS
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
WO2006025882A2 (fr) 2004-08-25 2006-03-09 The Uab Research Foundation Substances ameliorant l'absorption destinees a l'administration de medicaments
EP2076281A4 (fr) 2006-06-23 2010-03-03 Aegis Therapeutics Inc Compositions alkylglycosidiques stabilisatrices et leurs procédés
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
KR102512178B1 (ko) 2011-05-18 2023-03-20 메더리스 다이어비티즈, 엘엘씨 개선된 펩티드 제약
EP4047023A1 (fr) 2012-11-20 2022-08-24 Eumederis Pharmaceuticals, Inc. Produits pharmaceutiques de peptides améliorés
CA2891931A1 (fr) 2012-11-20 2014-05-30 Mederis Diabetes, Llc Produits pharmaceutiques peptidiques ameliores pour la resistance a l'insuline
WO2014140699A1 (fr) * 2013-03-13 2014-09-18 Calyx Chemicals And Pharmaceuticals Ltd Nouveau procédé de libération d'érythromycine et préparation de ses sels
KR20230084337A (ko) 2014-05-28 2023-06-12 메더리스 다이어비티즈, 엘엘씨 인슐린 저항성에 대한 개선된 펩티드 약제
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations
CU20190092A7 (es) * 2017-05-19 2020-10-20 Lunella Biotech Inc Antimitoscinas: inhibidores específicos de la biogénesis mitocondrial para erradicar células madre cancerosas
EP3717015A4 (fr) 2017-12-01 2021-07-28 Lunella Biotech, Inc. Repurposcins : inhibiteurs cibles de biogenèse mitochondriale pour éradiquer les cellules souches cancéreuses
JP6941224B2 (ja) 2018-02-06 2021-09-29 イージス セラピューティクス,エルエルシー 疾患の処置のための鼻腔内エピネフリン製剤及び方法
CA3088989C (fr) 2018-02-06 2023-03-07 Ars Pharmaceuticals Inc. Formulations d'epinephrine intranasale et methodes de traitement d'une maladie
KR20210104829A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 미토콘드리아를 표적화하고 암 줄기 세포를 사멸시키는 삼중 조합 요법
KR20210104830A (ko) * 2018-12-17 2021-08-25 루넬라 바이오테크 인코포레이티드 항노화를 위한 삼중 조합 요법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1179208A (fr) * 1953-11-16 1959-05-21 Abbott Lab Procédé de préparation de sels d'érythromycine
DE1011117B (de) * 1953-11-16 1957-06-27 Abbott Lab Verfahren zur Herstellung von reinen stabilen Erythromycin-Saeure-Additionssalzen
GB834397A (en) * 1958-07-29 1960-05-04 Lilly Co Eli Therapeutic compositions comprising erythromycin esters
US4150220A (en) * 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
US4599326A (en) 1986-07-08
YU44485B (en) 1990-08-31
ES539349A0 (es) 1986-04-01
ZA8410143B (en) 1985-08-28
CY1462A (en) 1989-07-21
GB2152502B (en) 1987-10-07
IE850022L (en) 1985-07-06
YU2085A (en) 1987-12-31
IE57967B1 (en) 1993-06-02
IT8519012A0 (it) 1985-01-04
AT386414B (de) 1988-08-25
DE3500179A1 (de) 1985-07-18
GB2152502A (en) 1985-08-07
BG43189A3 (en) 1988-04-15
SE8406671D0 (sv) 1984-12-28
FI77249B (fi) 1988-10-31
GB8432368D0 (en) 1985-02-06
PH22471A (en) 1988-09-12
HU196221B (en) 1988-10-28
FI77249C (fi) 1989-02-10
HK11590A (en) 1990-02-23
BE901411A (fr) 1985-04-16
AU565688B2 (en) 1987-09-24
DK149776B (da) 1986-09-29
PT79777A (en) 1985-01-01
FI850023L (fi) 1985-07-07
NO850007L (no) 1985-07-08
JPS60158197A (ja) 1985-08-19
ES8605818A1 (es) 1986-04-01
IS2968A7 (is) 1985-04-03
DK149776C (da) 1987-04-21
MX156277A (es) 1988-08-04
IL73885A (en) 1988-10-31
SU1410866A3 (ru) 1988-07-15
NO160263B (no) 1988-12-19
PT79777B (en) 1986-10-21
NO160263C (no) 1989-03-29
FR2557878B1 (fr) 1988-01-15
RO91262A (fr) 1987-06-30
NL8403979A (nl) 1985-08-01
IL73885A0 (en) 1985-03-31
FI850023A0 (fi) 1985-01-03
RO91262B (ro) 1987-07-01
CA1224461A (fr) 1987-07-21
DK5884A (da) 1985-07-07
PL251457A1 (en) 1985-11-05
CH666275A5 (de) 1988-07-15
IT1184304B (it) 1987-10-28
FR2557878A1 (fr) 1985-07-12
AU3705984A (en) 1985-07-11
DK5884D0 (da) 1984-01-06
SE461854B (sv) 1990-04-02
KR850005452A (ko) 1985-08-26
PL144349B1 (en) 1988-05-31
JPH029040B2 (fr) 1990-02-28
ATA985A (de) 1988-01-15
NZ210606A (en) 1987-08-31
SE8406671L (sv) 1985-07-07
KE3841A (en) 1989-04-07
KR900006237B1 (ko) 1990-08-27
HUT37628A (en) 1986-01-23
LU85721A1 (fr) 1985-07-24
DE3500179C2 (fr) 1989-08-24
CS247191B2 (en) 1986-12-18

Similar Documents

Publication Publication Date Title
MA20316A1 (fr) Compose antibiotique,procede pour le preparer et compositions les contenant
PH21995A (en) Antibiotic compounds, their composition and process for the preparation of said compound
GB2171695B (en) Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
BE890574A (fr) Derive d'aminoalcoyl-furanne, procede pour sa preparation et composition pharmaceutique le contenant
BE893010A (fr) Compose stable de sulfate de glucosamine, son procede de preparation et compositions pharmaceutiques les contenant
FI851269L (fi) Anlaeggning foer kontinuerlig pressning av en pressgodsmatta i samband med framstaellningen av spaonplattor, fiberplattor och liknande.
IL64345A (en) Substituted phenoxypropanolamine derivatives,process for the production thereof and pharmaceutical compositions containing the same
DE3167997D1 (en) Tetrazole derivatives, process for the preparation thereof, and anti-ulcer composition containing the same
FR2565227B1 (fr) 1,24-dihydroxy-22-vitamines d3 et procede pour les preparer
BE894527A (fr) Compositions pour composts
FR2554444B1 (fr) 1,25-dihydroxyvitamines d2 et procedes pour les preparer
IL62960A0 (en) Imidazoazole compounds,their production and pharmaceutical compositions containing them
FR2521135B1 (fr) Composes polyanioniques, procede pour les preparer et compositions les contenant
EP0159708A3 (en) Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for produing the same
FI823360A7 (fi) Uudet 3-fenyyli-1-indanamiinit ja menetelmä niiden valmistamiseksi ja niitä sisältävät koostumukset.
DE3266322D1 (en) Culture medium composition
FR2573762B1 (fr) Derives 4-hydroxyphenylthioalkyliques substitues, compositions les contenant et leur procede d'emploi
PH16945A (en) Substituted triphenyl thiazole compounds,their pharmaceutical compositions and their use
FR2510129B1 (fr) Compose d'addition et son procede de preparation
FR2590260B1 (fr) Nitro-anthracycline, aglycone correspondante, procedes pour les preparer, composition pharmaceutique correspondante
PT77428A (fr) Procede pour preparer de nouvelles amino-2-substitue-5-oxazoli-nes-2 et des compositions les contenant
DE3168544D1 (en) 6,7,8,9-tetrahydro-3h-benz(e)indolamine derivatives, processes for their preparation and intermediates used therein, and pharmaceutical compositions containing the indolamine derivatives
DE3264578D1 (en) Thio-substituted-1,3,5-triazine-diamines and -triamines useful as prevulcanization inhibitors
FR2549042B1 (fr) Procede pour la preparation de la 3,11-dimethyl-2-nonacosanone
MA20115A1 (fr) (Delta3-thiadiazoline-1,2,3 ylidene-5)-urees, procede pour les preparer et produits regulateurs de croissance et defoliants contenant de telles urees.